Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole
- 1 February 1997
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 53 (4) , 531-538
- https://doi.org/10.1016/s0006-2952(96)00769-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Genetic polymorphism of induction of CYP1A1 (EROD) activityPharmacogenetics, 1995
- Evaluation of Triacetyloleandomycin, α-Nasymphthoflavone and Diethyldithiocarbamate as Selective Chemical Probes for Inhibition of Human Cytochromes P450Archives of Biochemistry and Biophysics, 1994
- Characterization of the inhibition of P4501A2 by furafyllineXenobiotica, 1994
- Expression of CYP1A1 and CYP1A2 genes in human liverPharmacogenetics, 1993
- Fluvoxamine is a potent inhibitor of cytochrome P4501A2Biochemical Pharmacology, 1993
- In Vitro Methods for Assessing Human Hepatic Drug Metabolism: Their use in Drug DevelopmentDrug Metabolism Reviews, 1993
- Interaction Between Fluvoxamine and Imipramine/Desipramine in Four PatientsTherapeutic Drug Monitoring, 1992
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992
- Selective In-vitro Inhibition of Hepatic Oxidative Metabolism by Quinolones: 7-Ethoxyresorufin and Caffeine as Model SubstratesJournal of Pharmacy and Pharmacology, 1991
- Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissuesCarcinogenesis: Integrative Cancer Research, 1990